NQVAX | VEVYX | NQVAX / VEVYX | |
Total Expense Ratio | 1.16 | 0.66 | 176% |
Annual Report Gross Expense Ratio | 1.17 | 0.66 | 177% |
Fund Existence | 22 years | 12 years | - |
Gain YTD | 0.790 | -1.036 | -76% |
Front Load | 6% | N/A | - |
Min. Initial Investment | 2500 | 1000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 468M | 17.6B | 3% |
Annual Yield % from dividends | 1.35 | 1.15 | 117% |
Returns for 1 year | 10.38 | -7.03 | -148% |
Returns for 3 years | 42.60 | 0.06 | 66,929% |
Returns for 5 years | 141.39 | 61.97 | 228% |
Returns for 10 years | 129.27 | 43.40 | 298% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
QQQA | 42.65 | 0.43 | +1.02% |
ProShares Nasdaq-100 Drsy Wght Momt ETF | |||
IYF | 116.55 | 0.73 | +0.63% |
iShares US Financials ETF | |||
EMBD | 22.83 | 0.08 | +0.37% |
Global X Emerging Markets Bond ETF | |||
EMD | 9.61 | -0.01 | -0.10% |
Western Asset Emerging Markets Debt Fund | |||
SRTY | 19.29 | -0.23 | -1.18% |
ProShares UltraPro Short Russell2000 |